Knockdown of BCL2A1 restored apoptosis and reduced cell growth in the resistant AML cells without any substantial effect on the CD34+ hematopoietic stem and progenitor cells [65,94]. This evidence concerns the gene BCL2A1 and acute myeloid leukemia.